Patten Group, Inc. Gilead Sciences, Inc. Transaction History

Patten Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $3,126 - $3,502	-50 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $3,027 - $3,950	50 New	50 $3,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $9,266 - $10,259	-130 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $12,976 - $15,136	-200 Reduced 60.61%	130 $9,000
Q4 2017 Feb 02, 2018	SELL	$71.15 - $83.52 $14,941 - $17,539	-210 Reduced 38.89%	330 $24,000
Q3 2017 Dec 13, 2017	SELL	$72.11 - $85.47 $3.57 Million - $4.23 Million	-49,492 Reduced 98.92%	540 $44,000
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $3.57 Million - $4.23 Million	49,492 Added 9165.19%	50,032 $44,000
Q2 2017 Aug 14, 2017	BUY	N/A	540	540 $40,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Patten Group, Inc. with notifications on news.